Acarbose is pseudo-oligosaccharide with a terminal C7-cyclitol patented in 1975 by Bayer. Acarbose is a component of the amylostatin complex produced by species of Actinoplanes and Streptomyces. Acarbose acts as a potent inhibitor of α-glucosidases and saccharases. Since 1990, acarbose has been used therapeutically for the treatment of type 2 diabetes.
Acarbose is soluble in water with partial methanol, ethanol DMF and DMSO solubility.
Acarbose is soluble in water with partial methanol, ethanol DMF and DMSO solubility.